nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—CYP2E1—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0244	0.0304	CbGpPWpGaD
Cimetidine—FMO1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0243	0.0303	CbGpPWpGaD
Cimetidine—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0211	0.0263	CbGpPWpGaD
Cimetidine—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0209	0.026	CbGpPWpGaD
Cimetidine—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0188	0.0234	CbGpPWpGaD
Cimetidine—CYP11B1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.0176	0.0219	CbGpPWpGaD
Cimetidine—CYP11B1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0174	0.0217	CbGpPWpGaD
Cimetidine—FMO3—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0174	0.0216	CbGpPWpGaD
Cimetidine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0173	0.0216	CbGpPWpGaD
Cimetidine—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.0172	0.0214	CbGpPWpGaD
Cimetidine—Musculoskeletal pain—Varenicline—nicotine dependence	0.0155	0.0789	CcSEcCtD
Cimetidine—CYP2E1—Xenobiotics—CYP2A7—nicotine dependence	0.0151	0.0188	CbGpPWpGaD
Cimetidine—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.0151	0.0188	CbGpPWpGaD
Cimetidine—CYP11B1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0143	0.0178	CbGpPWpGaD
Cimetidine—FMO1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0137	0.0171	CbGpPWpGaD
Cimetidine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.0135	0.0168	CbGpPWpGaD
Cimetidine—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.0131	0.0163	CbGpPWpGaD
Cimetidine—FMO1—Biological oxidations—CYP2A7—nicotine dependence	0.0129	0.0161	CbGpPWpGaD
Cimetidine—FMO1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0127	0.0159	CbGpPWpGaD
Cimetidine—Disorientation—Varenicline—nicotine dependence	0.0124	0.0633	CcSEcCtD
Cimetidine—HRH2—Monoamine GPCRs—DRD2—nicotine dependence	0.0117	0.0146	CbGpPWpGaD
Cimetidine—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.0117	0.0145	CbGpPWpGaD
Cimetidine—Psychotic disorder—Varenicline—nicotine dependence	0.0109	0.0553	CcSEcCtD
Cimetidine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.0107	0.0134	CbGpPWpGaD
Cimetidine—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.0107	0.0133	CbGpPWpGaD
Cimetidine—Urinary retention—Varenicline—nicotine dependence	0.0106	0.0538	CcSEcCtD
Cimetidine—HRH2—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00984	0.0122	CbGpPWpGaD
Cimetidine—FMO3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0098	0.0122	CbGpPWpGaD
Cimetidine—FMO3—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00957	0.0119	CbGpPWpGaD
Cimetidine—FMO3—Biological oxidations—CYP2A7—nicotine dependence	0.00923	0.0115	CbGpPWpGaD
Cimetidine—FMO3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00911	0.0113	CbGpPWpGaD
Cimetidine—CYP1A2—Xenobiotics—CYP2A7—nicotine dependence	0.0091	0.0113	CbGpPWpGaD
Cimetidine—Erectile dysfunction—Varenicline—nicotine dependence	0.00884	0.0451	CcSEcCtD
Cimetidine—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00868	0.0108	CbGpPWpGaD
Cimetidine—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00857	0.0107	CbGpPWpGaD
Cimetidine—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00849	0.0433	CcSEcCtD
Cimetidine—CYP11B1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00806	0.01	CbGpPWpGaD
Cimetidine—Bradycardia—Varenicline—nicotine dependence	0.00783	0.0399	CcSEcCtD
Cimetidine—Hallucination—Varenicline—nicotine dependence	0.00765	0.039	CcSEcCtD
Cimetidine—CYP11B1—Biological oxidations—CYP2A7—nicotine dependence	0.0076	0.00945	CbGpPWpGaD
Cimetidine—CYP11B1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00749	0.00932	CbGpPWpGaD
Cimetidine—Erythema multiforme—Varenicline—nicotine dependence	0.00727	0.037	CcSEcCtD
Cimetidine—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00704	0.00876	CbGpPWpGaD
Cimetidine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00703	0.00874	CbGpPWpGaD
Cimetidine—Flatulence—Varenicline—nicotine dependence	0.00659	0.0336	CcSEcCtD
Cimetidine—FMO3—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00639	0.00795	CbGpPWpGaD
Cimetidine—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00629	0.00782	CbGpPWpGaD
Cimetidine—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00627	0.00781	CbGpPWpGaD
Cimetidine—CYP2E1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00621	0.00772	CbGpPWpGaD
Cimetidine—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00619	0.0077	CbGpPWpGaD
Cimetidine—Agitation—Varenicline—nicotine dependence	0.00615	0.0313	CcSEcCtD
Cimetidine—Malaise—Varenicline—nicotine dependence	0.00603	0.0307	CcSEcCtD
Cimetidine—FMO3—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0058	0.00722	CbGpPWpGaD
Cimetidine—Arthralgia—Varenicline—nicotine dependence	0.0057	0.029	CcSEcCtD
Cimetidine—Myalgia—Varenicline—nicotine dependence	0.0057	0.029	CcSEcCtD
Cimetidine—Anxiety—Varenicline—nicotine dependence	0.00568	0.0289	CcSEcCtD
Cimetidine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00543	0.00676	CbGpPWpGaD
Cimetidine—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00536	0.00667	CbGpPWpGaD
Cimetidine—Thrombocytopenia—Varenicline—nicotine dependence	0.00535	0.0272	CcSEcCtD
Cimetidine—Tachycardia—Varenicline—nicotine dependence	0.00533	0.0272	CcSEcCtD
Cimetidine—CYP2E1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.0051	0.00634	CbGpPWpGaD
Cimetidine—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00509	0.00633	CbGpPWpGaD
Cimetidine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00498	0.0254	CcSEcCtD
Cimetidine—Somnolence—Varenicline—nicotine dependence	0.00485	0.0247	CcSEcCtD
Cimetidine—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00485	0.00604	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—TAS2R16—nicotine dependence	0.00484	0.00602	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00483	0.00601	CbGpPWpGaD
Cimetidine—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00479	0.00596	CbGpPWpGaD
Cimetidine—Fatigue—Varenicline—nicotine dependence	0.00471	0.024	CcSEcCtD
Cimetidine—Constipation—Varenicline—nicotine dependence	0.00467	0.0238	CcSEcCtD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00458	0.00569	CbGpPWpGaD
Cimetidine—Feeling abnormal—Varenicline—nicotine dependence	0.0045	0.0229	CcSEcCtD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.0045	0.0056	CbGpPWpGaD
Cimetidine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00446	0.00555	CbGpPWpGaD
Cimetidine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00442	0.0055	CbGpPWpGaD
Cimetidine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00441	0.00548	CbGpPWpGaD
Cimetidine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0044	0.00548	CbGpPWpGaD
Cimetidine—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00437	0.00543	CbGpPWpGaD
Cimetidine—Body temperature increased—Varenicline—nicotine dependence	0.00432	0.022	CcSEcCtD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00426	0.00531	CbGpPWpGaD
Cimetidine—SLC47A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00416	0.00517	CbGpPWpGaD
Cimetidine—Hypersensitivity—Varenicline—nicotine dependence	0.00402	0.0205	CcSEcCtD
Cimetidine—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00397	0.00493	CbGpPWpGaD
Cimetidine—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00393	0.00489	CbGpPWpGaD
Cimetidine—Asthenia—Varenicline—nicotine dependence	0.00392	0.02	CcSEcCtD
Cimetidine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00378	0.0047	CbGpPWpGaD
Cimetidine—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00374	0.00465	CbGpPWpGaD
Cimetidine—Diarrhoea—Varenicline—nicotine dependence	0.00374	0.019	CcSEcCtD
Cimetidine—CYP1A2—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00373	0.00464	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—CHRNB3—nicotine dependence	0.0037	0.0046	CbGpPWpGaD
Cimetidine—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00369	0.00459	CbGpPWpGaD
Cimetidine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00362	0.0045	CbGpPWpGaD
Cimetidine—Dizziness—Varenicline—nicotine dependence	0.00361	0.0184	CcSEcCtD
Cimetidine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00359	0.00446	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—CHRNA6—nicotine dependence	0.00351	0.00436	CbGpPWpGaD
Cimetidine—Vomiting—Varenicline—nicotine dependence	0.00347	0.0177	CcSEcCtD
Cimetidine—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.00345	0.00429	CbGpPWpGaD
Cimetidine—Rash—Varenicline—nicotine dependence	0.00344	0.0175	CcSEcCtD
Cimetidine—Dermatitis—Varenicline—nicotine dependence	0.00344	0.0175	CcSEcCtD
Cimetidine—Headache—Varenicline—nicotine dependence	0.00342	0.0174	CcSEcCtD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00331	0.00412	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00327	0.00407	CbGpPWpGaD
Cimetidine—Nausea—Varenicline—nicotine dependence	0.00324	0.0165	CcSEcCtD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00317	0.00395	CbGpPWpGaD
Cimetidine—HRH2—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00313	0.00389	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00308	0.00384	CbGpPWpGaD
Cimetidine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00306	0.00381	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00296	0.00368	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00295	0.00367	CbGpPWpGaD
Cimetidine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00292	0.00363	CbGpPWpGaD
Cimetidine—SLC22A4—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00288	0.00358	CbGpPWpGaD
Cimetidine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00288	0.00358	CbGpPWpGaD
Cimetidine—CYP2E1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00287	0.00357	CbGpPWpGaD
Cimetidine—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00287	0.00357	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00275	0.00342	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00273	0.0034	CbGpPWpGaD
Cimetidine—CYP2E1—Biological oxidations—CYP2A7—nicotine dependence	0.00271	0.00337	CbGpPWpGaD
Cimetidine—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.0027	0.00336	CbGpPWpGaD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00268	0.00333	CbGpPWpGaD
Cimetidine—CYP2E1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00267	0.00332	CbGpPWpGaD
Cimetidine—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00266	0.00332	CbGpPWpGaD
Cimetidine—SLC22A11—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00257	0.0032	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.00253	0.00315	CbGpPWpGaD
Cimetidine—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00248	0.00309	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—TAS2R16—nicotine dependence	0.00248	0.00309	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.00243	0.00302	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.0024	0.00299	CbGpPWpGaD
Cimetidine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00236	0.00294	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.00236	0.00294	CbGpPWpGaD
Cimetidine—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.00234	0.00291	CbGpPWpGaD
Cimetidine—SLC22A7—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00233	0.0029	CbGpPWpGaD
Cimetidine—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00231	0.00287	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00226	0.00282	CbGpPWpGaD
Cimetidine—HRH2—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00226	0.00281	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.00226	0.00281	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00224	0.00279	CbGpPWpGaD
Cimetidine—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00222	0.00276	CbGpPWpGaD
Cimetidine—FMO1—Metabolism—CYP2A7—nicotine dependence	0.00221	0.00275	CbGpPWpGaD
Cimetidine—SLC22A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00217	0.0027	CbGpPWpGaD
Cimetidine—SLC22A5—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00217	0.00269	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—FGD1—nicotine dependence	0.00214	0.00267	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00212	0.00263	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.00211	0.00262	CbGpPWpGaD
Cimetidine—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00209	0.0026	CbGpPWpGaD
Cimetidine—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00206	0.00256	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—OPRM1—nicotine dependence	0.00204	0.00254	CbGpPWpGaD
Cimetidine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00204	0.00254	CbGpPWpGaD
Cimetidine—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00202	0.00251	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00197	0.00245	CbGpPWpGaD
Cimetidine—SLC22A8—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00196	0.00244	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—FGD1—nicotine dependence	0.00195	0.00242	CbGpPWpGaD
Cimetidine—HRH2—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00194	0.00241	CbGpPWpGaD
Cimetidine—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00192	0.00239	CbGpPWpGaD
Cimetidine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.00192	0.00239	CbGpPWpGaD
Cimetidine—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.0019	0.00237	CbGpPWpGaD
Cimetidine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00189	0.00236	CbGpPWpGaD
Cimetidine—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00188	0.00234	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.00184	0.00229	CbGpPWpGaD
Cimetidine—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00179	0.00223	CbGpPWpGaD
Cimetidine—CYP1A2—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00173	0.00215	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.00172	0.00214	CbGpPWpGaD
Cimetidine—SLC22A6—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00163	0.00203	CbGpPWpGaD
Cimetidine—CYP1A2—Biological oxidations—CYP2A7—nicotine dependence	0.00163	0.00203	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.00162	0.00202	CbGpPWpGaD
Cimetidine—CYP1A2—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00161	0.002	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—CYP2A7—nicotine dependence	0.00158	0.00196	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.00151	0.00188	CbGpPWpGaD
Cimetidine—HRH2—GPCR ligand binding—DRD2—nicotine dependence	0.00147	0.00183	CbGpPWpGaD
Cimetidine—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.00147	0.00183	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TAS2R16—nicotine dependence	0.00147	0.00182	CbGpPWpGaD
Cimetidine—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.00137	0.00171	CbGpPWpGaD
Cimetidine—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00136	0.0017	CbGpPWpGaD
Cimetidine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00133	0.00166	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—CYP2A7—nicotine dependence	0.0013	0.00162	CbGpPWpGaD
Cimetidine—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00127	0.00158	CbGpPWpGaD
Cimetidine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.00126	0.00156	CbGpPWpGaD
Cimetidine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00124	0.00154	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—OPRM1—nicotine dependence	0.00115	0.00143	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—FGD1—nicotine dependence	0.00115	0.00143	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—OPRM1—nicotine dependence	0.00105	0.0013	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—CYP2A7—nicotine dependence	0.00102	0.00127	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—AKR1B10—nicotine dependence	0.00102	0.00126	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—CYP2A7—nicotine dependence	0.000976	0.00121	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—DRD2—nicotine dependence	0.000833	0.00104	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—DRD2—nicotine dependence	0.000757	0.000941	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000744	0.000926	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—WASF2—nicotine dependence	0.000716	0.000891	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—WASF1—nicotine dependence	0.000687	0.000854	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000639	0.000795	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000638	0.000794	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—OPRM1—nicotine dependence	0.000618	0.000769	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000595	0.00074	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—CYP2A7—nicotine dependence	0.000463	0.000576	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000462	0.000575	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—DRD2—nicotine dependence	0.000447	0.000556	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CYP2A7—nicotine dependence	0.0004	0.000498	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000357	0.000444	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000349	0.000434	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000329	0.000409	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.000326	0.000405	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CYP2A7—nicotine dependence	0.000278	0.000346	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000215	0.000267	CbGpPWpGaD
